7Baggers
 CAR T-Cell Therapy Market will Reach USD 11.49 Billion by 2034 |  openPR.com Thu, 25 Sep 2025 13:09:15 GMT
 William Blair Maintains Autolus Therapeutics(AUTL.US) With Buy Rating  富途牛牛 Wed, 24 Sep 2025 08:31:00 GMT
 arrivent biopharma appoints brent rice as chief commercial officer  Investing.com Tue, 23 Sep 2025 03:00:53 GMT
 arrivent appoints brent s. rice as chief commercial officer  The Manila Times Mon, 22 Sep 2025 20:08:22 GMT
 published on: 2025-09-04 09:32:39  Newser Thu, 04 Sep 2025 14:32:39 GMT
 published on: 2025-09-04 05:35:21  Newser Thu, 04 Sep 2025 10:35:21 GMT
 how past endpoints 11 winners fared during 2025’s biotech downturn  Endpoints News Wed, 03 Sep 2025 11:00:00 GMT
 published on: 2025-09-02 07:18:29  Newser Tue, 02 Sep 2025 12:18:29 GMT
 published on: 2025-09-02 06:26:38  Newser Tue, 02 Sep 2025 11:26:38 GMT
 published on: 2025-08-31 20:59:34  Newser Mon, 01 Sep 2025 01:59:34 GMT
 published on: 2025-08-31 18:36:28  Newser Sun, 31 Aug 2025 23:36:28 GMT
 published on: 2025-08-31 16:48:50  Newser Sun, 31 Aug 2025 21:48:50 GMT
 autolus therapeutics q2 2025 earnings preview  MSN Sun, 31 Aug 2025 12:01:48 GMT
 published on: 2025-08-31 01:13:35  Newser Sun, 31 Aug 2025 06:13:35 GMT
 published on: 2025-08-30 22:04:27  Newser Sun, 31 Aug 2025 03:04:27 GMT
 published on: 2025-08-29 16:50:47  Newser Fri, 29 Aug 2025 21:50:47 GMT
 published on: 2025-08-29 14:26:32  Newser Fri, 29 Aug 2025 19:26:32 GMT
 published on: 2025-08-29 11:35:14  Newser Fri, 29 Aug 2025 16:35:14 GMT
 published on: 2025-08-29 08:27:36  Newser Fri, 29 Aug 2025 13:27:36 GMT
 published on: 2025-08-29 06:22:36  Newser Fri, 29 Aug 2025 11:22:36 GMT
 published on: 2025-08-28 22:27:14  Newser Fri, 29 Aug 2025 03:27:14 GMT
 published on: 2025-08-28 17:42:22  Newser Thu, 28 Aug 2025 22:42:22 GMT
 published on: 2025-08-28 13:59:23  Newser Thu, 28 Aug 2025 18:59:23 GMT
 published on: 2025-08-28 13:04:23  Newser Thu, 28 Aug 2025 18:04:23 GMT
 published on: 2025-08-28 05:08:54  Newser Thu, 28 Aug 2025 10:08:54 GMT
 published on: 2025-08-28 03:31:12  Newser Thu, 28 Aug 2025 08:31:12 GMT
 published on: 2025-08-27 13:58:50  Newser Wed, 27 Aug 2025 18:58:50 GMT

Autolus Therapeutics plc
(NASDAQ:AUTL) 

AUTL stock logo

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company is developing AUTO1 and AUTO3 for B cell malignancies; AUTO2 and AUTO8 for the treatment of multiple myeloma; AUTO1/22 for the treatment of dual-targeting CAR-T; A...

Founded: 2014
Full Time Employees: 290
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends